Cargando…
Sequential provocation of Ekbom’s syndrome and acute mania following AstraZeneca COVID-19 vaccination
ChAdOx1 nCoV-19 vaccine (so called AZ vaccine), is widely used to prevent the SARS-CoV-2 pandemic and shows powerful effectiveness to deter community transmission. There are common immunogenicity-related side effects such as fever, myalgia, lethargy, and headache; however, rare report on the neurops...
Autores principales: | Chang, Fang-Yu, Chen, Po-An, Siao, Wen-Huei, Chen, Yi-Chyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10039778/ https://www.ncbi.nlm.nih.gov/pubmed/37012199 http://dx.doi.org/10.1016/j.ajp.2023.103569 |
Ejemplares similares
-
AstraZeneca COVID-19 vaccine: thrombosis with thrombocytopenia
Publicado: (2021) -
Anaphylaxis in Australia with AstraZeneca's COVID-19 vaccine
Publicado: (2021) -
Vaccin Oxford/AstraZeneca, mode d’emploi
por: Dalmat, Yann-Mickael
Publicado: (2021) -
Oxford–AstraZeneca COVID-19 vaccine efficacy
por: Knoll, Maria Deloria, et al.
Publicado: (2021) -
AstraZeneca COVID-19 vaccine-related thromboembolism
Publicado: (2021)